• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

IPO

Medline Industries Northfield Illinois headquarters
MedTech

Medline sets terms for massive $5.37B Nasdaq IPO

The medical device manufacturing and distribution giant could claim a valuation of about $55 billion if it reaches the top of its range.
Conor Hale Dec 9, 2025 11:19am
A doctor is pointing at an x-ray of a human torso The background is white and in sharp contrast with the x-ray film

Lumexa Imaging eyes IPO expected to raise $200M

Nov 19, 2025 12:28pm
IPO initial public offering Wall Street

DNA test maker BillionToOne raises $314M in IPO, shares dip

Nov 10, 2025 8:45am
new york stock exchange

Inflammation biotech Evommune heads to NYSE with $150M IPO

Nov 6, 2025 7:00am
IPO art

Evommune prices IPO amid government shutdown

Oct 30, 2025 12:34pm
IPO initial public offering

MapLight goes public via $250M IPO to fund Cobenfy competitor

Oct 27, 2025 6:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings